首页> 外文期刊>Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research >Identification of 20(R, S)-protopanaxadiol and 20(R, S)-protopanaxatriol for potential selective modulation of glucocorticoid receptor
【24h】

Identification of 20(R, S)-protopanaxadiol and 20(R, S)-protopanaxatriol for potential selective modulation of glucocorticoid receptor

机译:鉴定20(R,S) - 丙酰基二醇和20(R,S) - 促磷酸二丙醇,用于含有糖皮质激素受体的潜在选择性调节

获取原文
获取原文并翻译 | 示例
           

摘要

Although glucocorticoids (GCs) are widely used as anti-inflammatory drugs, they are often accompanied by adverse effects, which are mainly due to the transactivation of glucocorticoid receptor (GR) target genes. In order to screen novel plant-derived GR ligands (phytocorticoids) capable of separating transrepression from transactivation, this work focuses on the estimation of 20(R, S)-protopanaxadiol [PPD(R, S)] and 20(R, S)-protopanaxatriol [PPT(R, S)] for their dissociated characteristics. The reporter gene assay shows that ginsenosides cannot enhance glucocorticoid-responsive element-driven genes. The cytotoxicity assay shows that PPT(S), PPT(R), and PPD(S) can inhibit cell proliferation while PPD(R) does not suppress cell growth at available concentration. Further analysis of transactivation and transrepression activities indicates that PPD(R) can repress the transcription of GR target transrepressed gene without activating the expression of the GR target transactivated gene. Results of molecular docking suggest that PPD(R) yields more hydrogen bond interactions and a lower binding energy than its counterparts, resulting in tighter binding between PPD(R) and GR. In addition, PPD(R) achieves stability in the pocket after 2 ns, thereby facilitating exerting its regulatory role of GR target genes. By contrast, other ginsenosides fluctuate drastically during the simulations. In conclusion, PPD(R) may serve as a potential selective GR modulator (SEGRM).
机译:虽然糖皮质激素(GCS)被广泛用作抗炎药,但它们通常伴有不良反应,这主要是由于糖皮质激素受体(GR)靶基因的反膜激活。为了筛选能够分离转基因的新型植物衍生的GR配体(植物皮质激素),这项工作侧重于20(R,S) - 促进(R,S)和20(R,S)的估计-Stropanaxatriol [ppt(r,s)]用于它们的解离特性。报告基因测定表明,人参皂苷不能增强糖皮质激素响应性元素驱动的基因。细胞毒性测定结果表明,PPT(r)不能在可用浓度下抑制细胞生长的同时抑制细胞增殖的PPT。进一步分析转基因和转膜功能和转膜功能表明PPD(R)可以抑制GR靶转发基因的转录而不激活GR靶转移基因的表达。分子对接的结果表明,PPD(R)产生更多的氢键相互作用和比其对应物更低的结合能量,导致PPD(R)和GR之间的更紧密结合。此外,PPD(R)在2NS之后在口袋中实现稳定性,从而促进施加其GR靶基因的调节作用。相比之下,在模拟期间,其他人参皂甙急剧地波动。总之,PPD(R)可以用作潜在的选择性GR调节剂(SEGRM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号